Y Mabs Therapeutics Stock Momentum Indicators 1 day Rate Of Change of a Triple Smooth EMA

YMAB Stock  USD 11.88  1.11  10.31%   
Y MAbs momentum indicators tool provides the execution environment for running the 1 day Rate Of Change of a Triple Smooth EMA indicator and other technical functions against Y MAbs. Y MAbs value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of momentum indicators indicators. As with most other technical indicators, the 1 day Rate Of Change of a Triple Smooth EMA indicator function is designed to identify and follow existing trends. Momentum indicators of Y MAbs are pattern recognition functions that provide distinct formation on Y MAbs potential trading signals or future price movement. Analysts can use these trading signals to identify current and future trends and trend reversals to provide buy and sell recommendations. Please specify Time Period to run this model.

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The 1-day Rate-Of-Change (ROC) of a Triple Smooth EMA is an alternative momentum indicator that shows Y mAbs Therapeutics trend by ignoring insignificant cycles.

Y MAbs Technical Analysis Modules

Most technical analysis of Y MAbs help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for YMAB from various momentum indicators to cycle indicators. When you analyze YMAB charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Y MAbs Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Y mAbs Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Y mAbs Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing YMAB Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Y MAbs's daily price indicators and compare them against related drivers, such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Y MAbs's intrinsic value. In addition to deriving basic predictive indicators for Y MAbs, we also check how macroeconomic factors affect Y MAbs price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 (projected)
Days Sales Outstanding70.0896.6365.97
PTB Ratio1.952.952.8
Hype
Prediction
LowEstimatedHigh
8.1111.8815.65
Details
Intrinsic
Valuation
LowRealHigh
6.6410.4114.18
Details
Naive
Forecast
LowNextHigh
8.0311.8015.58
Details
9 Analysts
Consensus
LowTargetHigh
11.3112.4313.80
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Y MAbs. Your research has to be compared to or analyzed against Y MAbs' peers to derive any actionable benefits. When done correctly, Y MAbs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Y mAbs Therapeutics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Y MAbs in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Y MAbs' short interest history, or implied volatility extrapolated from Y MAbs options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Y mAbs Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Y MAbs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Y Mabs Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Y Mabs Therapeutics Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Y mAbs Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Y MAbs. If investors know YMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Y MAbs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.54)
Revenue Per Share
1.921
Quarterly Revenue Growth
(0.1)
Return On Assets
(0.12)
Return On Equity
(0.25)
The market value of Y mAbs Therapeutics is measured differently than its book value, which is the value of YMAB that is recorded on the company's balance sheet. Investors also form their own opinion of Y MAbs' value that differs from its market value or its book value, called intrinsic value, which is Y MAbs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Y MAbs' market value can be influenced by many factors that don't directly affect Y MAbs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Y MAbs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Y MAbs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Y MAbs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.